Page last updated: 2024-12-05

phosphorus pentoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

phosphorus pentoxide: drying agent for bacterial cultural extracts analyzed by gas-liquid chromatography; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

diphosphonate(2-) : A divalent inorganic anion obtained by removal of both protons from diphosphonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6326975
CHEBI ID29262
MeSH IDM0059567

Synonyms (23)

Synonym
CHEBI:29262
diphosphonate
mu-oxido-bis(hydridodioxidophosphate)(2-)
p2h2o5(2-)
[o2p(h)op(h)(o)2](2-)
diphosphonate(2-)
phosphorus oxide (p2o5)
phosphorus(v) oxide
phosphorus pentoxide
1314-56-3
P1746
phosphorus (v) pentoxide
AKOS015903585
BP-21050
XQRLCLUYWUNEEH-UHFFFAOYSA-L
mfcd00011440
FT-0697548
J-006006
phosphorus pentoxide (p2o5) granular
Q27109994
337913-25-4
A851563
diphosphorpentaoxid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (126)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (10.32)18.7374
1990's23 (18.25)18.2507
2000's34 (26.98)29.6817
2010's51 (40.48)24.3611
2020's5 (3.97)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.77%)5.53%
Reviews1 (0.77%)6.00%
Case Studies2 (1.54%)4.05%
Observational0 (0.00%)0.25%
Other126 (96.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]